Understanding emerging bioactive metabolites with putative roles in cancer biology

Area of Science:

• Oncology
• Metabolomics
• Proteomics

Background:

• Cancer cells exhibit significant metabolic dysregulation to support rapid biosynthesis.
• Metabolites can possess direct bioactive functions beyond serving as metabolic precursors.
• The roles of these bioactive metabolites in cancer progression are largely uncharacterized.

Purpose of the Study:

• To review recently identified bioactive metabolites and their potential roles in cancer.
• To highlight the significance of metabolite post-translational modifications (PTMs) in cancer.
• To propose novel approaches for studying these bioactive roles and interactions.

Main Methods:

• Summary of current literature on bioactive metabolites in cancer.
• Discussion of emerging metabolomic and proteomic techniques.
• Focus on identifying novel PTMs and metabolite-protein interactions.

Main Results:

• Several metabolites have been identified with direct bioactive roles in human cells.
• These metabolites can function as post-translational modifications (PTMs) on proteins.
• Their specific impact on cancer cell phenotypes remains an area for further investigation.

Conclusions:

• Bioactive metabolites, particularly as PTMs, represent an underappreciated aspect of cancer biology.
• Novel metabolomic and proteomic strategies are crucial for defining these roles.
• Understanding these interactions may unveil new therapeutic targets for cancer treatment.